Books > Law > Laws of other jurisdictions & general law > Financial, taxation, commercial, industrial law > Commercial law
|
Buy Now
Competition Law and Policy in the Japanese Pharmaceutical Sector (Hardcover, 1st ed. 2022)
Loot Price: R4,044
Discovery Miles 40 440
|
|
Competition Law and Policy in the Japanese Pharmaceutical Sector (Hardcover, 1st ed. 2022)
Series: Kobe University Monograph Series in Social Science Research
Expected to ship within 12 - 17 working days
|
This is the first book published that focuses on competition law
and policy in the Japanese pharmaceutical sector. It consists of
chapters written and edited by academics who research the industry
from various perspectives, including economics, competition law,
pharmaceutical regulations, and intellectual property law.
Competition policies involving pharmaceutical products attract
attention from academics and policymakers worldwide. The
pharmaceutical industry is regulated by drug laws that vary from
country to country and are affected by differing practices and
industrial structures. The book begins by examining drug
regulations and trade practices in the industry that are peculiar
to Japan and its healthcare system. It then presents the Japanese
Antimonopoly Act and cases involving it, and discussions of current
competition law issues in the Japanese pharmaceutical industry. The
book also discusses innovation and intellectual property and
economic analyses of pharmaceutical regulations and drug discovery.
The chapters include comparative studies on Japanese regulations
vs. those in the European Union and the United States. Japan is one
of the biggest pharmaceutical markets in the world. With this in
mind, the book provides "one-stop shopping" for anyone interested
in pharmaceutical regulations in the country. Covering the basics
but extending to in-depth explorations of complex problems, this
book appeals not only to students and academics, pharmaceutical
companies and regulators, but also to those dealing with real-world
policy issues that encompass competition policy, intellectual
property, and pharmaceutical regulation. Chapter 11 is available
open access under a Creative Commons Attribution 4.0 International
License via link.springer.com
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.